Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
Pulse Biosciences
PLSE
$4.19B
| $1.19M | ﹤0.01% |
23,789
+20,621
| +651% | +$870K |
2017 Q1
38 quarters
|
|
2902
Shoals Technologies Group
SHLS
$1.48B
| $1.19M | ﹤0.01% |
146,468
+92,172
| +170% | +$776K |
2022 Q1
18 quarters
|
|
2903
Janux Therapeutics
JANX
$758M
| $1.19M | ﹤0.01% |
68,611
+4,932
| +8% | +$82.9K |
2022 Q1
18 quarters
|
|
2904
CALL
Aflac
AFL
$62.9B
| $1.18M | ﹤0.01% |
+10,600
| New | +$1.27M |
2026 Q3
0 quarters
|
|
2905
Takeda Pharmaceutical
TAK
$66.6B
| $1.18M | ﹤0.01% |
64,911
+60,119
| +1,255% | +$1.06M |
2018 Q4
31 quarters
|
|
2906
LegalZoom.com
LZ
$796M
| $1.18M | ﹤0.01% |
210,453
+121,796
| +137% | +$796K |
2021 Q2
21 quarters
|
|
2907
Arhaus
ARHS
$2.06B
| $1.18M | ﹤0.01% |
124,544
-5,136
| -4% | -$43.8K |
2022 Q4
15 quarters
|
|
2908
Gevo
GEVO
$450M
| $1.18M | ﹤0.01% |
895,538
+225,030
| +34% | +$350K |
2022 Q2
17 quarters
|
|
2909
PUT
ConocoPhillips
COP
$163B
| $1.18M | ﹤0.01% |
+9,400
| New | +$1.16M |
2026 Q3
0 quarters
|
|
2910
La-Z-Boy
LZB
$1.32B
| $1.17M | ﹤0.01% |
39,583
-3,315
| -8% | -$119K |
2013 Q2
53 quarters
|
|
2911
California Water Service
CWT
$3.12B
| $1.17M | ﹤0.01% |
25,331
+14,198
| +128% | +$703K |
2013 Q2
53 quarters
|
|
2912
Gibraltar Industries
ROCK
$970M
| $1.17M | ﹤0.01% |
29,597
-2,134
| -7% | -$95.7K |
2016 Q3
40 quarters
|
|
2913
Hawkins
HWKN
$3.16B
| $1.17M | ﹤0.01% |
9,301
+5,644
| +154% | +$733K |
2016 Q2
41 quarters
|
|
2914
Adeia
ADEA
$1.89B
| $1.17M | ﹤0.01% |
45,774
+23,080
| +102% | +$620K |
2022 Q1
18 quarters
|
|
2915
Kforce
KFRC
$987M
| $1.17M | ﹤0.01% |
22,297
+9,557
| +75% | +$529K |
2016 Q2
41 quarters
|
|
2916
Boost Run Inc
BRUN
$587M
| $1.17M | ﹤0.01% |
70,889
-11,623
| -14% | -$238K |
2026 Q2
1 quarter
|
|
2917
Interparfums
IPAR
$4.27B
| $1.17M | ﹤0.01% |
10,520
+7,253
| +222% | +$856K |
2016 Q1
42 quarters
|
|
2918
Bank First Corp
BFC
$1.67B
| $1.17M | ﹤0.01% |
7,840
+346
| +5% | +$52.5K |
2019 Q2
29 quarters
|
|
2919
Agilysys
AGYS
$3.48B
| $1.16M | ﹤0.01% |
11,992
+7,330
| +157% | +$790K |
2016 Q1
42 quarters
|
|
2920
Fresenius Medical Care
FMS
$11.5B
| $1.16M | ﹤0.01% |
+51,911
| New | +$1.22M |
2026 Q3
0 quarters
|
|
2921
PUT
Ares Management
ARES
$31.4B
| $1.16M | ﹤0.01% |
10,000
| – | – |
2025 Q4
3 quarters
|
|
2922
Kailera Therapeutics
KLRA
$1.87B
| $1.16M | ﹤0.01% |
101,280
+90,949
| +880% | +$1.54M |
2026 Q2
1 quarter
|
|
2923
Fox Factory Holding Corp
FOXF
$739M
| $1.16M | ﹤0.01% |
62,937
+251
| +0.4% | +$4.85K |
2016 Q3
40 quarters
|
|
2924
Heritage Insurance Holdings
HRTG
$996M
| $1.16M | ﹤0.01% |
34,858
+10,517
| +43% | +$332K |
2016 Q3
40 quarters
|
|
2925
First Commonwealth Financial
FCF
$2.04B
| $1.15M | ﹤0.01% |
57,080
-3,599
| -6% | -$75.7K |
2016 Q3
40 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.